WO2023094429A1 - Régions promotrices artificielles de levure - Google Patents
Régions promotrices artificielles de levure Download PDFInfo
- Publication number
- WO2023094429A1 WO2023094429A1 PCT/EP2022/082939 EP2022082939W WO2023094429A1 WO 2023094429 A1 WO2023094429 A1 WO 2023094429A1 EP 2022082939 W EP2022082939 W EP 2022082939W WO 2023094429 A1 WO2023094429 A1 WO 2023094429A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- protein
- interest
- yeast
- expression
- promoter region
- Prior art date
Links
- 240000004808 Saccharomyces cerevisiae Species 0.000 title claims abstract description 126
- 108700039691 Genetic Promoter Regions Proteins 0.000 title claims abstract description 55
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 147
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 104
- 230000014509 gene expression Effects 0.000 claims abstract description 85
- 239000002773 nucleotide Substances 0.000 claims abstract description 61
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 61
- 108700028146 Genetic Enhancer Elements Proteins 0.000 claims abstract description 44
- 238000000034 method Methods 0.000 claims abstract description 31
- 108700026226 TATA Box Proteins 0.000 claims abstract description 15
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 114
- 210000004027 cell Anatomy 0.000 claims description 48
- 238000004519 manufacturing process Methods 0.000 claims description 34
- 102000004190 Enzymes Human genes 0.000 claims description 22
- 108090000790 Enzymes Proteins 0.000 claims description 22
- 230000027455 binding Effects 0.000 claims description 22
- 108020004705 Codon Proteins 0.000 claims description 17
- 241001099156 Komagataella phaffii Species 0.000 claims description 17
- 241000235015 Yarrowia lipolytica Species 0.000 claims description 17
- 108091081024 Start codon Proteins 0.000 claims description 11
- 101000841411 Homo sapiens Protein ecdysoneless homolog Proteins 0.000 claims description 8
- 241000320412 Ogataea angusta Species 0.000 claims description 8
- 102100029090 Protein ecdysoneless homolog Human genes 0.000 claims description 8
- 210000005253 yeast cell Anatomy 0.000 claims description 8
- 241001138401 Kluyveromyces lactis Species 0.000 claims description 7
- 230000037353 metabolic pathway Effects 0.000 claims description 7
- 241000235058 Komagataella pastoris Species 0.000 claims description 6
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 6
- 241000235346 Schizosaccharomyces Species 0.000 claims description 6
- 230000015556 catabolic process Effects 0.000 claims description 6
- 241000235650 Kluyveromyces marxianus Species 0.000 claims description 5
- 229930013930 alkaloid Natural products 0.000 claims description 5
- 241000235036 Debaryomyces hansenii Species 0.000 claims description 4
- 235000014663 Kluyveromyces fragilis Nutrition 0.000 claims description 4
- 241000223254 Rhodotorula mucilaginosa Species 0.000 claims description 4
- 235000018368 Saccharomyces fragilis Nutrition 0.000 claims description 4
- 229940031154 kluyveromyces marxianus Drugs 0.000 claims description 4
- 102000004316 Oxidoreductases Human genes 0.000 claims description 3
- 108090000854 Oxidoreductases Proteins 0.000 claims description 3
- 102000006010 Protein Disulfide-Isomerase Human genes 0.000 claims description 3
- 239000002551 biofuel Substances 0.000 claims description 3
- 150000001720 carbohydrates Chemical class 0.000 claims description 3
- 108020003519 protein disulfide isomerase Proteins 0.000 claims description 3
- 108010001535 sulfhydryl oxidase Proteins 0.000 claims description 3
- 230000001131 transforming effect Effects 0.000 claims description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 2
- 101100078103 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) MSN4 gene Proteins 0.000 claims description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 claims description 2
- 101150039048 GCR1 gene Proteins 0.000 claims 1
- 102100037248 Prolyl hydroxylase EGLN2 Human genes 0.000 claims 1
- 101710170760 Prolyl hydroxylase EGLN2 Proteins 0.000 claims 1
- 235000018102 proteins Nutrition 0.000 description 87
- 229940088598 enzyme Drugs 0.000 description 21
- 108010039224 Amidophosphoribosyltransferase Proteins 0.000 description 17
- IGMNYECMUMZDDF-UHFFFAOYSA-N homogentisic acid Chemical compound OC(=O)CC1=CC(O)=CC=C1O IGMNYECMUMZDDF-UHFFFAOYSA-N 0.000 description 17
- 125000000539 amino acid group Chemical group 0.000 description 16
- 230000037361 pathway Effects 0.000 description 13
- OINNEUNVOZHBOX-XBQSVVNOSA-N Geranylgeranyl diphosphate Natural products [P@](=O)(OP(=O)(O)O)(OC/C=C(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C)O OINNEUNVOZHBOX-XBQSVVNOSA-N 0.000 description 11
- 150000001413 amino acids Chemical class 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 239000002609 medium Substances 0.000 description 11
- 150000007523 nucleic acids Chemical class 0.000 description 11
- 239000011731 tocotrienol Substances 0.000 description 11
- 102100022524 Alpha-1-antichymotrypsin Human genes 0.000 description 10
- 101000678026 Homo sapiens Alpha-1-antichymotrypsin Proteins 0.000 description 10
- 235000001014 amino acid Nutrition 0.000 description 10
- 229940024606 amino acid Drugs 0.000 description 10
- OINNEUNVOZHBOX-QIRCYJPOSA-K 2-trans,6-trans,10-trans-geranylgeranyl diphosphate(3-) Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\COP([O-])(=O)OP([O-])([O-])=O OINNEUNVOZHBOX-QIRCYJPOSA-K 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 108091005957 yellow fluorescent proteins Proteins 0.000 description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
- 108091026890 Coding region Proteins 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 229910052799 carbon Inorganic materials 0.000 description 8
- 239000013604 expression vector Substances 0.000 description 8
- 239000008103 glucose Substances 0.000 description 8
- 238000012269 metabolic engineering Methods 0.000 description 8
- 108020004707 nucleic acids Proteins 0.000 description 8
- 102000039446 nucleic acids Human genes 0.000 description 8
- JTTIOYHBNXDJOD-UHFFFAOYSA-N 2,4,6-triaminopyrimidine Chemical compound NC1=CC(N)=NC(N)=N1 JTTIOYHBNXDJOD-UHFFFAOYSA-N 0.000 description 7
- 101000724418 Homo sapiens Neutral amino acid transporter B(0) Proteins 0.000 description 7
- 101000579123 Homo sapiens Phosphoglycerate kinase 1 Proteins 0.000 description 7
- 102100028267 Neutral amino acid transporter B(0) Human genes 0.000 description 7
- KJWZYMMLVHIVSU-IYCNHOCDSA-N PGK1 Chemical compound CCCCC[C@H](O)\C=C\[C@@H]1[C@@H](CCCCCCC(O)=O)C(=O)CC1=O KJWZYMMLVHIVSU-IYCNHOCDSA-N 0.000 description 7
- 102100028251 Phosphoglycerate kinase 1 Human genes 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- 230000010354 integration Effects 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- 229930003802 tocotrienol Natural products 0.000 description 7
- 235000019148 tocotrienols Nutrition 0.000 description 7
- 238000013518 transcription Methods 0.000 description 7
- 230000035897 transcription Effects 0.000 description 7
- 230000014616 translation Effects 0.000 description 7
- 108010011619 6-Phytase Proteins 0.000 description 6
- 101150080339 BTS1 gene Proteins 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 101500023488 Lithobates catesbeianus GnRH-associated peptide 1 Proteins 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 6
- 229940085127 phytase Drugs 0.000 description 6
- 239000002243 precursor Substances 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 6
- 239000011732 tocopherol Substances 0.000 description 6
- 238000013519 translation Methods 0.000 description 6
- 239000013598 vector Substances 0.000 description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 5
- KKADPXVIOXHVKN-UHFFFAOYSA-N 4-hydroxyphenylpyruvic acid Chemical compound OC(=O)C(=O)CC1=CC=C(O)C=C1 KKADPXVIOXHVKN-UHFFFAOYSA-N 0.000 description 5
- 108091035707 Consensus sequence Proteins 0.000 description 5
- 230000004075 alteration Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 238000012217 deletion Methods 0.000 description 5
- 230000037430 deletion Effects 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- 238000005457 optimization Methods 0.000 description 5
- 230000002018 overexpression Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 229940068778 tocotrienols Drugs 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- GJJVAFUKOBZPCB-ZGRPYONQSA-N (r)-3,4-dihydro-2-methyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-2h-1-benzopyran-6-ol Chemical class OC1=CC=C2OC(CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-ZGRPYONQSA-N 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- OINNEUNVOZHBOX-QIRCYJPOSA-N 2-trans,6-trans,10-trans-geranylgeranyl diphosphate Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\COP(O)(=O)OP(O)(O)=O OINNEUNVOZHBOX-QIRCYJPOSA-N 0.000 description 4
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 4
- 108020004635 Complementary DNA Proteins 0.000 description 4
- 101001026885 Homo sapiens Serine/threonine-protein kinase D3 Proteins 0.000 description 4
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 4
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 4
- 102100037311 Serine/threonine-protein kinase D3 Human genes 0.000 description 4
- -1 amides aspartate Chemical class 0.000 description 4
- 235000009582 asparagine Nutrition 0.000 description 4
- 229960001230 asparagine Drugs 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 238000010804 cDNA synthesis Methods 0.000 description 4
- 239000002299 complementary DNA Substances 0.000 description 4
- SNRUBQQJIBEYMU-UHFFFAOYSA-N dodecane Chemical compound CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 4
- 230000004907 flux Effects 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- 229930003799 tocopherol Natural products 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 108010059892 Cellulase Proteins 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 108010007508 Farnesyltranstransferase Proteins 0.000 description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
- 239000004472 Lysine Substances 0.000 description 3
- 108700011259 MicroRNAs Proteins 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- 101150055709 SNF1 gene Proteins 0.000 description 3
- 101100010928 Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2) tuf gene Proteins 0.000 description 3
- 241000235070 Saccharomyces Species 0.000 description 3
- 101100280133 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) EUG1 gene Proteins 0.000 description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 3
- 101150001810 TEAD1 gene Proteins 0.000 description 3
- 101150074253 TEF1 gene Proteins 0.000 description 3
- 108091023040 Transcription factor Proteins 0.000 description 3
- 102000040945 Transcription factor Human genes 0.000 description 3
- 102100029898 Transcriptional enhancer factor TEF-1 Human genes 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000034659 glycolysis Effects 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 239000002679 microRNA Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 229910052711 selenium Inorganic materials 0.000 description 3
- 239000011669 selenium Substances 0.000 description 3
- JXOHGGNKMLTUBP-HSUXUTPPSA-N shikimic acid Chemical compound O[C@@H]1CC(C(O)=O)=C[C@@H](O)[C@H]1O JXOHGGNKMLTUBP-HSUXUTPPSA-N 0.000 description 3
- JXOHGGNKMLTUBP-JKUQZMGJSA-N shikimic acid Natural products O[C@@H]1CC(C(O)=O)=C[C@H](O)[C@@H]1O JXOHGGNKMLTUBP-JKUQZMGJSA-N 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- 239000011593 sulfur Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 235000019149 tocopherols Nutrition 0.000 description 3
- 108091006106 transcriptional activators Proteins 0.000 description 3
- 239000007222 ypd medium Substances 0.000 description 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 2
- OJISWRZIEWCUBN-QIRCYJPOSA-N (E,E,E)-geranylgeraniol Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CO OJISWRZIEWCUBN-QIRCYJPOSA-N 0.000 description 2
- KJTLQQUUPVSXIM-ZCFIWIBFSA-M (R)-mevalonate Chemical compound OCC[C@](O)(C)CC([O-])=O KJTLQQUUPVSXIM-ZCFIWIBFSA-M 0.000 description 2
- GJJVAFUKOBZPCB-UHFFFAOYSA-N 2-methyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-ol Chemical compound OC1=CC=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-UHFFFAOYSA-N 0.000 description 2
- VWFJDQUYCIWHTN-YFVJMOTDSA-N 2-trans,6-trans-farnesyl diphosphate Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CO[P@](O)(=O)OP(O)(O)=O VWFJDQUYCIWHTN-YFVJMOTDSA-N 0.000 description 2
- ODADKLYLWWCHNB-UHFFFAOYSA-N 2R-delta-tocotrienol Natural products OC1=CC(C)=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 ODADKLYLWWCHNB-UHFFFAOYSA-N 0.000 description 2
- OTXNTMVVOOBZCV-UHFFFAOYSA-N 2R-gamma-tocotrienol Natural products OC1=C(C)C(C)=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 OTXNTMVVOOBZCV-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 2
- 102000004672 Acetyl-CoA C-acyltransferase Human genes 0.000 description 2
- 108010003902 Acetyl-CoA C-acyltransferase Proteins 0.000 description 2
- 101100389688 Arabidopsis thaliana AERO1 gene Proteins 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241001240438 Candida hispaniensis Species 0.000 description 2
- KJTLQQUUPVSXIM-UHFFFAOYSA-N DL-mevalonic acid Natural products OCCC(O)(C)CC(O)=O KJTLQQUUPVSXIM-UHFFFAOYSA-N 0.000 description 2
- 101000609814 Dictyostelium discoideum Protein disulfide-isomerase 1 Proteins 0.000 description 2
- 101150047030 ERO1 gene Proteins 0.000 description 2
- 101150050883 ERV2 gene Proteins 0.000 description 2
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 2
- VWFJDQUYCIWHTN-FBXUGWQNSA-N Farnesyl diphosphate Natural products CC(C)=CCC\C(C)=C/CC\C(C)=C/COP(O)(=O)OP(O)(O)=O VWFJDQUYCIWHTN-FBXUGWQNSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 102100039291 Geranylgeranyl pyrophosphate synthase Human genes 0.000 description 2
- 102000006587 Glutathione peroxidase Human genes 0.000 description 2
- 108700016172 Glutathione peroxidases Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 102100040870 Glycine amidinotransferase, mitochondrial Human genes 0.000 description 2
- 101000893303 Homo sapiens Glycine amidinotransferase, mitochondrial Proteins 0.000 description 2
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical group CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 102100025169 Max-binding protein MNT Human genes 0.000 description 2
- 102000016397 Methyltransferase Human genes 0.000 description 2
- 108060004795 Methyltransferase Proteins 0.000 description 2
- 101100390535 Mus musculus Fdft1 gene Proteins 0.000 description 2
- 101100390536 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) erg-6 gene Proteins 0.000 description 2
- 101100099277 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) rgt-1 gene Proteins 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
- 108020001027 Ribosomal DNA Proteins 0.000 description 2
- 101100165033 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) AZF1 gene Proteins 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- 101150039209 VTE1 gene Proteins 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 101710185494 Zinc finger protein Proteins 0.000 description 2
- 102100023597 Zinc finger protein 816 Human genes 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 229940106157 cellulase Drugs 0.000 description 2
- LLEJIEBFSOEYIV-UHFFFAOYSA-N chelerythrine Chemical compound C1=C2OCOC2=CC2=CC=C3C4=CC=C(OC)C(OC)=C4C=[N+](C)C3=C21 LLEJIEBFSOEYIV-UHFFFAOYSA-N 0.000 description 2
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 2
- 230000004186 co-expression Effects 0.000 description 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N ***e Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- BTNBMQIHCRIGOU-UHFFFAOYSA-N delta-tocotrienol Natural products CC(=CCCC(=CCCC(=CCCOC1(C)CCc2cc(O)cc(C)c2O1)C)C)C BTNBMQIHCRIGOU-UHFFFAOYSA-N 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 101150116391 erg9 gene Proteins 0.000 description 2
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 239000012737 fresh medium Substances 0.000 description 2
- ASUTZQLVASHGKV-JDFRZJQESA-N galanthamine Chemical compound O1C(=C23)C(OC)=CC=C2CN(C)CC[C@]23[C@@H]1C[C@@H](O)C=C2 ASUTZQLVASHGKV-JDFRZJQESA-N 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 235000021472 generally recognized as safe Nutrition 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- XWRJRXQNOHXIOX-UHFFFAOYSA-N geranylgeraniol Natural products CC(C)=CCCC(C)=CCOCC=C(C)CCC=C(C)C XWRJRXQNOHXIOX-UHFFFAOYSA-N 0.000 description 2
- OJISWRZIEWCUBN-UHFFFAOYSA-N geranylnerol Natural products CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCO OJISWRZIEWCUBN-UHFFFAOYSA-N 0.000 description 2
- 230000002414 glycolytic effect Effects 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 230000006801 homologous recombination Effects 0.000 description 2
- 238000002744 homologous recombination Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 239000001573 invertase Substances 0.000 description 2
- 235000011073 invertase Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- KXFJZKUFXHWWAJ-UHFFFAOYSA-N p-hydroxybenzoylformic acid Natural products OC(=O)C(=O)C1=CC=C(O)C=C1 KXFJZKUFXHWWAJ-UHFFFAOYSA-N 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 239000005014 poly(hydroxyalkanoate) Substances 0.000 description 2
- 229920000903 polyhydroxyalkanoate Polymers 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- LOUPRKONTZGTKE-LHHVKLHASA-N quinidine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@H]2[C@@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-LHHVKLHASA-N 0.000 description 2
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical group CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 108010057392 tocopherol cyclase Proteins 0.000 description 2
- 125000002640 tocopherol group Chemical class 0.000 description 2
- 108091006107 transcriptional repressors Proteins 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- RXPRRQLKFXBCSJ-GIVPXCGWSA-N vincamine Chemical compound C1=CC=C2C(CCN3CCC4)=C5[C@@H]3[C@]4(CC)C[C@](O)(C(=O)OC)N5C2=C1 RXPRRQLKFXBCSJ-GIVPXCGWSA-N 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 235000019144 δ-tocotrienol Nutrition 0.000 description 2
- 239000011729 δ-tocotrienol Substances 0.000 description 2
- ODADKLYLWWCHNB-LDYBVBFYSA-N δ-tocotrienol Chemical compound OC1=CC(C)=C2O[C@@](CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1 ODADKLYLWWCHNB-LDYBVBFYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- FDKWRPBBCBCIGA-REOHCLBHSA-N (2r)-2-azaniumyl-3-$l^{1}-selanylpropanoate Chemical compound [Se]C[C@H](N)C(O)=O FDKWRPBBCBCIGA-REOHCLBHSA-N 0.000 description 1
- HNSDLXPSAYFUHK-UHFFFAOYSA-N 1,4-bis(2-ethylhexyl) sulfosuccinate Chemical compound CCCCC(CC)COC(=O)CC(S(O)(=O)=O)C(=O)OCC(CC)CCCC HNSDLXPSAYFUHK-UHFFFAOYSA-N 0.000 description 1
- RSGINGXWCXYMQU-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-hydroxypropanoate Chemical compound CC(O)C(=O)OCC(O)CO RSGINGXWCXYMQU-UHFFFAOYSA-N 0.000 description 1
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 1
- YMHOBZXQZVXHBM-UHFFFAOYSA-N 2,5-dimethoxy-4-bromophenethylamine Chemical compound COC1=CC(CCN)=C(OC)C=C1Br YMHOBZXQZVXHBM-UHFFFAOYSA-N 0.000 description 1
- XMWHRVNVKDKBRG-UHNVWZDZSA-N 2-C-Methyl-D-erythritol 4-phosphate Natural products OC[C@@](O)(C)[C@H](O)COP(O)(O)=O XMWHRVNVKDKBRG-UHNVWZDZSA-N 0.000 description 1
- 108020005345 3' Untranslated Regions Proteins 0.000 description 1
- SEBPXHSZHLFWRL-UHFFFAOYSA-N 3,4-dihydro-2,2,5,7,8-pentamethyl-2h-1-benzopyran-6-ol Chemical group O1C(C)(C)CCC2=C1C(C)=C(C)C(O)=C2C SEBPXHSZHLFWRL-UHFFFAOYSA-N 0.000 description 1
- LKKMLIBUAXYLOY-UHFFFAOYSA-N 3-Amino-1-methyl-5H-pyrido[4,3-b]indole Chemical compound N1C2=CC=CC=C2C2=C1C=C(N)N=C2C LKKMLIBUAXYLOY-UHFFFAOYSA-N 0.000 description 1
- 102100028626 4-hydroxyphenylpyruvate dioxygenase Human genes 0.000 description 1
- 108010068327 4-hydroxyphenylpyruvate dioxygenase Proteins 0.000 description 1
- 101150058005 ARO3 gene Proteins 0.000 description 1
- 101150114788 ARO4 gene Proteins 0.000 description 1
- 108091006112 ATPases Proteins 0.000 description 1
- 101100148259 Actinobacillus pleuropneumoniae apxIIA gene Proteins 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102000004400 Aminopeptidases Human genes 0.000 description 1
- 108090000915 Aminopeptidases Proteins 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108700042778 Antimicrobial Peptides Proteins 0.000 description 1
- 102000044503 Antimicrobial Peptides Human genes 0.000 description 1
- 101000655644 Arabidopsis thaliana Acetyl-CoA acetyltransferase, cytosolic 1 Proteins 0.000 description 1
- 101100178203 Arabidopsis thaliana HMGB3 gene Proteins 0.000 description 1
- 102100029361 Aromatase Human genes 0.000 description 1
- 241001523626 Arxula Species 0.000 description 1
- 101100020886 Aspergillus niger leu2A gene Proteins 0.000 description 1
- 102100039339 Atrial natriuretic peptide receptor 1 Human genes 0.000 description 1
- 101710102163 Atrial natriuretic peptide receptor 1 Proteins 0.000 description 1
- 102100032487 Beta-mannosidase Human genes 0.000 description 1
- 241000680806 Blastobotrys adeninivorans Species 0.000 description 1
- 108091033409 CRISPR Proteins 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 102000005367 Carboxypeptidases Human genes 0.000 description 1
- 108010006303 Carboxypeptidases Proteins 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 108010031396 Catechol oxidase Proteins 0.000 description 1
- 102000030523 Catechol oxidase Human genes 0.000 description 1
- 108010022172 Chitinases Proteins 0.000 description 1
- 102000012286 Chitinases Human genes 0.000 description 1
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- 241000192700 Cyanobacteria Species 0.000 description 1
- 101710095468 Cyclase Proteins 0.000 description 1
- FDKWRPBBCBCIGA-UWTATZPHSA-N D-Selenocysteine Natural products [Se]C[C@@H](N)C(O)=O FDKWRPBBCBCIGA-UWTATZPHSA-N 0.000 description 1
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 1
- 101710096438 DNA-binding protein Proteins 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- RATMHCJTVBHJSU-UHFFFAOYSA-N Dihydrochelerythrine Natural products C1=C2OCOC2=CC2=C(N(C)C(O)C=3C4=CC=C(C=3OC)OC)C4=CC=C21 RATMHCJTVBHJSU-UHFFFAOYSA-N 0.000 description 1
- 108010028143 Dioxygenases Proteins 0.000 description 1
- 102000016680 Dioxygenases Human genes 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 210000000712 G cell Anatomy 0.000 description 1
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 102100022624 Glucoamylase Human genes 0.000 description 1
- 102100033039 Glutathione peroxidase 1 Human genes 0.000 description 1
- 108010070675 Glutathione transferase Proteins 0.000 description 1
- 102000005720 Glutathione transferase Human genes 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 102100022662 Guanylyl cyclase C Human genes 0.000 description 1
- 101710198293 Guanylyl cyclase C Proteins 0.000 description 1
- HVLSXIKZNLPZJJ-TXZCQADKSA-N HA peptide Chemical compound C([C@@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 HVLSXIKZNLPZJJ-TXZCQADKSA-N 0.000 description 1
- 101150091750 HMG1 gene Proteins 0.000 description 1
- 108700010013 HMGB1 Proteins 0.000 description 1
- 101150021904 HMGB1 gene Proteins 0.000 description 1
- 101710106540 Heme-responsive zinc finger transcription factor HAP1 Proteins 0.000 description 1
- 102100037907 High mobility group protein B1 Human genes 0.000 description 1
- 101000919395 Homo sapiens Aromatase Proteins 0.000 description 1
- 101001014936 Homo sapiens Glutathione peroxidase 1 Proteins 0.000 description 1
- 101001081533 Homo sapiens Isopentenyl-diphosphate Delta-isomerase 1 Proteins 0.000 description 1
- 101001114059 Homo sapiens Protein-arginine deiminase type-1 Proteins 0.000 description 1
- 101000716758 Homo sapiens Sec1 family domain-containing protein 1 Proteins 0.000 description 1
- 101000664600 Homo sapiens Tripartite motif-containing protein 3 Proteins 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 102100027665 Isopentenyl-diphosphate Delta-isomerase 1 Human genes 0.000 description 1
- 101150108662 KAR2 gene Proteins 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- 241000235649 Kluyveromyces Species 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 102100031413 L-dopachrome tautomerase Human genes 0.000 description 1
- 101710093778 L-dopachrome tautomerase Proteins 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 108010029541 Laccase Proteins 0.000 description 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- 108010033024 Phospholipid Hydroperoxide Glutathione Peroxidase Proteins 0.000 description 1
- 102100023410 Phospholipid hydroperoxide glutathione peroxidase Human genes 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 101710169714 Phytase AppA Proteins 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 102000055027 Protein Methyltransferases Human genes 0.000 description 1
- 108700040121 Protein Methyltransferases Proteins 0.000 description 1
- 102100023222 Protein-arginine deiminase type-1 Human genes 0.000 description 1
- KDCGOANMDULRCW-UHFFFAOYSA-N Purine Natural products N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 101150014136 SUC2 gene Proteins 0.000 description 1
- 101100216804 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) ARO10 gene Proteins 0.000 description 1
- 101100163488 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) ARO8 gene Proteins 0.000 description 1
- 101100163489 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) ARO9 gene Proteins 0.000 description 1
- 101100172613 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) ERG10 gene Proteins 0.000 description 1
- 101100389693 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) ERO1 gene Proteins 0.000 description 1
- 101100065653 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) ERV2 gene Proteins 0.000 description 1
- 101100336281 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GCR1 gene Proteins 0.000 description 1
- 101100336283 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GCR2 gene Proteins 0.000 description 1
- 101100337690 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GPX1 gene Proteins 0.000 description 1
- 101100177159 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) HAC1 gene Proteins 0.000 description 1
- 101100111629 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) KAR2 gene Proteins 0.000 description 1
- 101100238341 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) MPD1 gene Proteins 0.000 description 1
- 101100082596 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) PDC5 gene Proteins 0.000 description 1
- 101100243108 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) PDI1 gene Proteins 0.000 description 1
- 101100297423 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) PHD1 gene Proteins 0.000 description 1
- 101100313649 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) POT1 gene Proteins 0.000 description 1
- 101100477003 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) SEC1 gene Proteins 0.000 description 1
- 101100203394 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) SLY1 gene Proteins 0.000 description 1
- 241000235347 Schizosaccharomyces pombe Species 0.000 description 1
- 102100020874 Sec1 family domain-containing protein 1 Human genes 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 108020004459 Small interfering RNA Proteins 0.000 description 1
- 101000882406 Staphylococcus aureus Enterotoxin type C-1 Proteins 0.000 description 1
- 101100114901 Streptomyces griseus crtI gene Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 101000997953 Sulfolobus acidocaldarius (strain ATCC 33909 / DSM 639 / JCM 8929 / NBRC 15157 / NCIMB 11770) Digeranylgeranylglycerophospholipid reductase Proteins 0.000 description 1
- 241000192584 Synechocystis Species 0.000 description 1
- 108010044281 TATA-Box Binding Protein Proteins 0.000 description 1
- 102000006467 TATA-Box Binding Protein Human genes 0.000 description 1
- 108030003984 Thiol oxidases Proteins 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 108700009124 Transcription Initiation Site Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 108060008539 Transglutaminase Proteins 0.000 description 1
- 102100038798 Tripartite motif-containing protein 3 Human genes 0.000 description 1
- 108091023045 Untranslated Region Proteins 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241000545067 Venus Species 0.000 description 1
- 241000222057 Xanthophyllomyces dendrorhous Species 0.000 description 1
- 241000235013 Yarrowia Species 0.000 description 1
- 108091007916 Zinc finger transcription factors Proteins 0.000 description 1
- 102000038627 Zinc finger transcription factors Human genes 0.000 description 1
- XMWHRVNVKDKBRG-CRCLSJGQSA-N [(2s,3r)-2,3,4-trihydroxy-3-methylbutyl] dihydrogen phosphate Chemical compound OC[C@](O)(C)[C@@H](O)COP(O)(O)=O XMWHRVNVKDKBRG-CRCLSJGQSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 108091022873 acetoacetate decarboxylase Proteins 0.000 description 1
- 108091000039 acetoacetyl-CoA reductase Proteins 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N adenyl group Chemical group N1=CN=C2N=CNC2=C1N GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 102000005840 alpha-Galactosidase Human genes 0.000 description 1
- 108010030291 alpha-Galactosidase Proteins 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002058 anti-hyperglycaemic effect Effects 0.000 description 1
- 230000000078 anti-malarial effect Effects 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 239000003430 antimalarial agent Substances 0.000 description 1
- 101150050411 appA gene Proteins 0.000 description 1
- 101150032070 aro7 gene Proteins 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229930015408 benzyl-isoquinoline alkaloid Natural products 0.000 description 1
- 150000005516 benzylisoquinolines Chemical class 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 108010047754 beta-Glucosidase Proteins 0.000 description 1
- 102000006995 beta-Glucosidase Human genes 0.000 description 1
- 108010055059 beta-Mannosidase Proteins 0.000 description 1
- 102000006635 beta-lactamase Human genes 0.000 description 1
- 238000011138 biotechnological process Methods 0.000 description 1
- 238000013452 biotechnological production Methods 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 108010089934 carbohydrase Proteins 0.000 description 1
- 230000006860 carbon metabolism Effects 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 230000000718 cholinopositive effect Effects 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 229940060799 clarus Drugs 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 229960003920 ***e Drugs 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 101150000046 crtE gene Proteins 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 108010005400 cutinase Proteins 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- RXPRRQLKFXBCSJ-UHFFFAOYSA-N dl-Vincamin Natural products C1=CC=C2C(CCN3CCC4)=C5C3C4(CC)CC(O)(C(=O)OC)N5C2=C1 RXPRRQLKFXBCSJ-UHFFFAOYSA-N 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- 230000008686 ergosterol biosynthesis Effects 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 108010000165 exo-1,3-alpha-glucanase Proteins 0.000 description 1
- 230000008713 feedback mechanism Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000001997 free-flow electrophoresis Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 229960003980 galantamine Drugs 0.000 description 1
- ASUTZQLVASHGKV-UHFFFAOYSA-N galanthamine hydrochloride Natural products O1C(=C23)C(OC)=CC=C2CN(C)CCC23C1CC(O)C=C2 ASUTZQLVASHGKV-UHFFFAOYSA-N 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 102000054767 gene variant Human genes 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 229940049906 glutamate Drugs 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960002743 glutamine Drugs 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- HYFHYPWGAURHIV-UHFFFAOYSA-N homoharringtonine Natural products C1=C2CCN3CCCC43C=C(OC)C(OC(=O)C(O)(CCCC(C)(C)O)CC(=O)OC)C4C2=CC2=C1OCO2 HYFHYPWGAURHIV-UHFFFAOYSA-N 0.000 description 1
- 101150047832 hpt gene Proteins 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000006525 intracellular process Effects 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000006109 methionine Nutrition 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- HYFHYPWGAURHIV-JFIAXGOJSA-N omacetaxine mepesuccinate Chemical compound C1=C2CCN3CCC[C@]43C=C(OC)[C@@H](OC(=O)[C@@](O)(CCCC(C)(C)O)CC(=O)OC)[C@H]4C2=CC2=C1OCO2 HYFHYPWGAURHIV-JFIAXGOJSA-N 0.000 description 1
- 229960002230 omacetaxine mepesuccinate Drugs 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 230000002351 pectolytic effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000000813 peptide hormone Substances 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 230000000858 peroxisomal effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 244000059219 photoautotrophic organism Species 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 108010078060 phytyltransferase Proteins 0.000 description 1
- WVWHRXVVAYXKDE-UHFFFAOYSA-N piperine Natural products O=C(C=CC=Cc1ccc2OCOc2c1)C3CCCCN3 WVWHRXVVAYXKDE-UHFFFAOYSA-N 0.000 description 1
- MXXWOMGUGJBKIW-YPCIICBESA-N piperine Chemical compound C=1C=C2OCOC2=CC=1/C=C/C=C/C(=O)N1CCCCC1 MXXWOMGUGJBKIW-YPCIICBESA-N 0.000 description 1
- 229940075559 piperine Drugs 0.000 description 1
- 235000019100 piperine Nutrition 0.000 description 1
- 230000020824 plant-type cell wall organization Effects 0.000 description 1
- 108010010718 poly(3-hydroxyalkanoic acid) synthase Proteins 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000012846 protein folding Effects 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 230000006337 proteolytic cleavage Effects 0.000 description 1
- 230000021156 pseudohyphal growth Effects 0.000 description 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
- 229960001404 quinidine Drugs 0.000 description 1
- 229960000948 quinine Drugs 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000014493 regulation of gene expression Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 235000016491 selenocysteine Nutrition 0.000 description 1
- ZKZBPNGNEQAJSX-UHFFFAOYSA-N selenocysteine Natural products [SeH]CC(N)C(O)=O ZKZBPNGNEQAJSX-UHFFFAOYSA-N 0.000 description 1
- 229940055619 selenocysteine Drugs 0.000 description 1
- 235000004400 serine Nutrition 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 238000001542 size-exclusion chromatography Methods 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000037351 starvation Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 235000008521 threonine Nutrition 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 102000003601 transglutaminase Human genes 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 229930004668 tropane alkaloid Natural products 0.000 description 1
- 150000003813 tropane derivatives Chemical class 0.000 description 1
- 101150042775 tyr1 gene Proteins 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000000825 ultraviolet detection Methods 0.000 description 1
- 230000009452 underexpressoin Effects 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 229960002726 vincamine Drugs 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/102—Plasmid DNA for yeast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
Definitions
- the invention relates to methods for optimizing expression of a protein of interest in a yeast host cell.
- Yeasts such as Saccharomyces cerevisiae and Schizosaccharomyces pom.be are renowned as production facilities for a protein of interest. Deletion mutants of every open reading frame (Scherens and Goffeau, 2004. Genome Biol 5: 229; Kim et al., 2010. Nat Biotechnol 28: 617-623) have resulted in a thorough understanding of the biological roles of many of the genes.
- the Saccharomyces Genome Database (SGD; available at yeastgenome.org/) provides information about each and every yeast gene, including the effects of over- and under-expression or deletion of a gene.
- yeast species that are adapted to the process conditions and can tolerate the mechanical forces in a bioreactor, inhibitory substances and fermentation products.
- divers yeast products have obtained GRAS (generally recognized as safe) status by the FDA, while the European Food Safety Authority (EFSA) has provided a list of organisms, termed Qualified Presumption of Safety (QPS), which includes several yeast strains.
- GRAS generally recognized as safe
- EFSA European Food Safety Authority
- yeasts The knowledge of intracellular processes such as metabolism, secretion, transport, signaling and other pathways, and the availability of a large tool set for genetic engineering, have made yeasts the workhorse for a wide variety of applications.
- heterologous protein requires control over gene expression to optimize product formation.
- Transcriptional control for example the strength of a promoter and possible feedback mechanisms, are critical points for yeast engineering.
- This new generation of yeast promoter sequences preferably drive expression of a protein at different levels, allowing expression of a gene at a requested level.
- the invention described herein is based on numerous artificial yeast promoter regions, comprising different promoter elements such as enhancer elements and TATA boxes at varying positions, that were tested in different yeast strains. These tests resulted in the identification of a minimal number of promoter elements that provide tailored expression levels of a protein in the yeast strains tested.
- the invention provides an artificial yeast promoter region, comprising a TATA box at position -90 ⁇ 15 nucleotides (nt), and/or a TATA box at position -160 ⁇ 15 nt, an enhancer element at position -350 ⁇ 25 nucleotides, and a second enhancer element at position -600 ⁇ 50 nucleotides, wherein said enhancer element at position -350 ⁇ 25 nucleotides is selected from a Asparagine -rich Zinc-Finger 1 (AZFI) binding element and a Multicopy suppressor of SNF1 mutation (MSN4) binding element, wherein said enhancer element at position -600 ⁇ 50 nucleotides is selected from a GlyColysis Regulation 1 (GCR1) binding element, a GCR2 binding element, and a PseudoHyphal Determinant 1 (PHD1) binding element, wherein all positions are relative to the start codon ATG, and wherein the sequences in between the indicated TATA boxes and enhancer elements
- the enhancer elements are not positioned at their natural distance to the start codon.
- the enhancer element at position -350 ⁇ 25 nucleotides is preferably 5’-AAMRGMA or 5’-RVCCCCYR.
- the second enhancer element at position -600 ⁇ 50 nucleotides is preferably selected from 5’-WGGAWGMY, 5’-WGGAAGNM, and 5’-VMTGCRKV.
- TATA box is present at position -90 ⁇ 15 nucleotides (nt), at position -160 ⁇ 15 nt, or at both positions - 90 ⁇ 15 nucleotides (nt) and -160 ⁇ 15 nt.
- Said artificial yeast promoter region is able to drive expression of a downstream protein in at least one of Kluyverontyces marxianus, Kluyveromyces lactis, Komagataella pastoris, Komagataella phaffii, Ogataea angusta, Yarrowia lipolytica, Schizosaccharomyces pom.be, Rhodotorula mucilaginosa, Candida famata and Saccharomyces cerevisiae, preferably at least in one of K phaffii, Y. lipolytica and S. cerevisiae.
- the nucleotide sequences of the promoter region are preferably identical to any one of SEQ ID NO:s 1-33, over a length of at least 600 nucleotides.
- the invention further provides an expression construct comprising the artificial yeast promoter region of the invention, for expression of a protein of interest in a yeast.
- Said expression construct preferably comprises a nucleotide sequence encoding a protein of interest under control of the artificial yeast promoter region.
- Said nucleotide sequence encoding the protein of interest preferably is codon optimized for expression in a yeast host cell.
- the invention further provides a yeast host cell, comprising the artificial yeast promoter region of the invention, or the expression construct according the invention.
- the invention further provides a method of producing a protein of interest in a yeast host cell, comprising providing an expression construct according to the invention, transforming a yeast cell with the expression construct, expressing the protein of interest; and, optionally, at least partly purifying the protein of interest.
- the invention further provides method of producing a protein of interest in a yeast host cell, comprising providing the yeast host cell comprising the expression construct according to the invention, expressing the protein of interest; and, optionally, at least partly purifying the protein of interest.
- the protein of interest is preferably tagged.
- the protein of interest may be co-expressed in the yeast cell with one or more of a protein disulfide isomerase, a flavin-linked sulfhydryl oxidase, and an oxidoreductase.
- the protein of interest may be part of a metabolic pathway, the method further comprising modulating the expression levels of one or more other enzymes in the metabolic pathway.
- Said metabolic pathway may be selected from the production of a biofuel, the breakdown of a carbohydrate, the production of a biopolyester, the production of a tocochromanol, and the production of an alkaloid.
- Fig. 1 Cultivation of K. phaffii in media containing three different carbon sources to express YFP as a reporter under control of different promoters with a high strength.
- Fig. 2 Cultivation of K. phaffii in medium containing two different carbon sources to express YFP as a reporter under control of various promoters with a medium strength.
- Fig. 3 Cultivation of Y. lipolytica to express GFP as a reporter under control of the different promoters as indicated with a high strength (A), or with a similar fluorescence (B), when compared to a reference promoter.
- Fig. 4 Cultivation of S. cerevisiae to express YFP as a reporter under control of the different promoters with a high strength.
- Fig. 5 Cultivation of S. cerevisiae to express YFP as a reporter under control of the different promoters with a medium strength.
- Fig. 6 Cultivation of S. cerevisiae for production of geranylgeraniol under control of the promoter EPK14 compared to the reference promoter.
- Fig. 7 Cultivation of K. phaffii in media containing three different carbon sources for expression of phytase AppA from E. coli under control of the promoters EPK2 and EPK3 compared to the reference promoter.
- Fig. 8 Normalized specific activity of phytase with PDI co-expression compared to the AppA production strain, which did not express PDI.
- substantially(ly) refers to the general character or function which is specified. When referring to a quantifiable feature, these term is in particular used to indicate that it is for at least 75 %, more in particular at least 90 %, even more in particular at least 95 % of the indicated feature.
- a “substantially pure” compound or protein refers to a purity of at least 95%, more preferably at least 96 %, at least 97 %, at least 98 %, at least 99 % or at least 100 % pure compound or protein, as determined by standard analytical techniques known in the art.
- yeast refers to a eukaryotic, unicellular microorganism that is classified as a member of the kingdom fungus.
- a preferred yeast is a yeast of the Saccharomyces sensu stricto complex (Hittinger, 2013. Trends Genet 29: 309-317; Naseeb et al., 2017.
- Int J Syst Evol Microbiol 67: 2046- 2052) such as the species Saccharomyces cerevisiae, a methylotrophic yeast such as Komagataella pastoris, Komagataella phaffii (both together formerly known as Pichia pastoris) and Ogataea angusta (formerly known as Hansenula polymorpha), a fission yeast such as Schizosaccharomyces pom.be, a Kluyveromyces species such as K. lactis and K. marxianus, a Yarrowia species such as Y. lipolytica, and a Arxula species such as Arxula adeninivorans.
- Saccharomyces cerevisiae a methylotrophic yeast such as Komagataella pastoris, Komagataella phaffii (both together formerly known as Pichia pastoris) and Ogataea angusta
- a fission yeast
- gene refers to a nucleic acid molecule comprising a protein-coding or RNA-coding sequence such as miRNA or siRNA, in an expressible form, operably linked to a regulatory sequence, including a promoter and optionally other regulatory sequences that are required to control expression of the coding sequence.
- heterologous gene refers to any gene or coding sequence of a gene that does not naturally occur in the species wherein it is expressed.
- transformation refers to the introduction of a nucleotide sequence such as a plasmid into a cell.
- the term preferably refers to stable integration of a nucleotide sequence such as a plasmid into the genome of a cell.
- encoding refers to the information to guide translation of a nucleotide sequence of a nucleic acid molecule into a specified protein.
- the information by which a protein is encoded is specified by codons, i.e. a trinucleotide sequence of DNA or RNA that corresponds to a specific amino acid.
- a nucleic acid molecule encoding a protein may comprise a non-translated sequence, e.g., an intron, interspersed with translated regions of the nucleic acid or may lack such an intervening non-translated sequence, e.g., as in complementary DNA (cDNA).
- cDNA complementary DNA
- mRNA messenger RNA
- miRNA microRNA
- operably linked refers to the association of two or more nucleic acid fragments on a single nucleic acid molecule so that the function of one is affected by the other.
- a promoter region is operably linked to a coding sequence when the promoter region is capable of affecting the expression of said coding sequence.
- the coding sequence is under transcriptional control of the promoter region.
- express refers to the process of transcription or/or translation of a gene.
- promoter region refers to a nucleotide sequence upstream or surrounding a transcription start site that controls binding of an RNA polymerase.
- a coding sequence or functional RNA is located downstream of a promoter.
- TATA box refers to an element in the promoter region that functions as initiating site for a transcription complex comprising TATA-binding protein.
- a TATA box consensus sequence comprises the nucleotide sequence 5’-TATA(A/T)A(A/T)(A/G), and thus includes the sequences 5'- TATAAAAA, 5'-TATAAAAG, 5'-TATAAATA, 5'-TATAAATG, 5'-TATATAAA, 5'- TATATAAG, 5'-TATATATA and 5'-TATATATG.
- small alterations from this consensus sequence such as 1 or 2 alterations, may be tolerated.
- regulatory element refers to a nucleotide sequence located upstream, interspersed with, or downstream of a promoter that influences transcription, RNA processing or stability, or translation of the associated coding sequence.
- a regulatory element may include an enhancer element, translational leader sequence (5’ untranslated regions (UTR), intron, trailer sequence (3’ UTR), and a polyadenylation sequence.
- enhancer element refers to a specific nucleotide sequence that can stimulate promoter activity. In general, an enhancer functions independent of its exact position relative to a promoter.
- alteration refers to a change in a nucleic acid sequence of a gene compared to the nucleic acid sequence of a non- altered gene. Said change preferably is a change that affects the functionality of the gene. Encompassed in the term alteration is deletion of one or more, including all, nucleotides from the gene, substitution of one or more nucleotides in the gene, and insertion of one or more nucleotides into the gene, or a combination thereof.
- substitution refers at a nucleic acid level to a change of one or more nucleotides into one or more other nucleotides, whilst the total number of nucleotides remain the same.
- substitution at the amino acid level is a change of one or more amino acid residues into one or more other amino acid residues, whilst the total number of amino acid residues remains the same.
- protein refers to a chain of amino acids arranged in a specific order determined by the coding sequence in a nucleic acid molecule encoding the protein.
- sequence identity refers to the percentage of identical residues determined by comparing two optimally aligned sequences over a comparison window. Said two sequences are preferably compared over the full length of the shortest of two sequences. The percentage is calculated by determining the number of positions at which an identical nucleic acid base or amino acid residue occurs in both sequences to yield the number of matched positions, dividing the number of matched positions by the total number of positions in the window of comparison, and multiplying the result by 100 to yield the percentage of sequence identity.
- purifying refers to at least partly separating of a compound or protein of interest from its environment. Purifying encompasses separating a fluid comprising said compound or protein of interest from solids such as cells and debris to obtain a fluid comprising the compound or protein of interest and optionally one or more other substances. Purifying further encompasses removal of impurities and other substances until the compound or protein of interest is substantially pure.
- This invention provides an artificial yeast promoter region, comprising one or two TATA boxes and two enhancer elements.
- a first TATA box is present at position -90 ⁇ 15 nucleotides (nt) relative to the translation start codon ATG, while a second TATA box is present at position -160 ⁇ 15 nt.
- Said artificial promoter region is further characterized by the presence of two enhancer elements, a first element at position -350 ⁇ 25 nucleotides, and a second enhancer element at position -600 ⁇ 50 nucleotides.
- nucleotide sequences in between the indicated TATA boxes and enhancer elements were shuffled sequences from existing yeast promoter regions. Care was taken when designing these promoter regions to eliminate possible transcriptional repressor elements such as ACR1 (5’-ATGACGTCA; Vincent and Struhl, 1992. Mol Cell Biol 12: 5394-5405), Roxl QiNTVGWN,- Pevny and Lovell-Badge, 1997. Curr Opin Genet Dev 7: 338-344), and Rgt 1 (5'-CGGANNA; Kim, 2009. Biochimie 91: 300-303).
- A represents adenine
- G represents guanine
- C represents cytosine
- T represents thymine
- Y represents a pyrimidine (C or T)
- R represents a purine (A or G)
- W represents weak (A or T)
- S represents strong (G or C)
- K represents keto (T or G)
- M represents amino (C or A)
- D represents A, G, T (not C)
- V represents A, C, G (not T)
- H represents A, C, T (not G)
- B represents C, G, T (not A)
- X or N represents any base.
- a gap is denoted by a
- Said first and second enhancer elements may be any enhancer element, provided that the first enhancer element differs from the second enhancer element, and that the first and second enhancer elements bind different transcription activating proteins.
- said first and second enhancer element preferably bind a transcription activating protein in substantially all yeasts, preferably at least in one or more of Saccharomyces cerevisiae, Komagataella pastoris, Komagataella phaffii, Ogataea angusta, Schizosaccharomyces pom.be, Kluyveromyces lactis, Kluyveromyces marxianus, Yarrowia lipolytica, Rhodotorula mucilaginosa and Candida famata.
- Said first and second enhancer elements are not positioned at their natural position relative to the start codon ATG.
- MSN4 encodes a Cys2His2 zinc finger protein that binds to a stress- responsive element termed STRE in the promoter region of several genes, having the consensus sequence 5’-RVCCCCYR, normally resides at around position.
- An artificial yeast promoter region according to the invention may be provided by fixing two TATA boxes at positions -90 ⁇ 15 nucleotides (nt) and/or - 160 ⁇ 15 nt, relative to the translation start codon ATG, a first enhancer element at position -350 ⁇ 25 nucleotides, and a second enhancer element at position -600 ⁇ 50 nucleotides.
- the sequences in between these elements may be obtained from common yeast promoter regions, but are preferably shuffled or scrambled so that they sufficiently differ from existing promoter sequences.
- a total length of a promoter region according to the invention is between 600 and 1200 nt, such as between 700 and 1000 nt, such as around 800 nt.
- Said first and second enhancer element may provide a binding site for any known yeast transcription factor such as, for example, Sterile 12 (Stel2), Heme Activator Protein 1 (Hapl), Asparagine -rich Zinc-Finger 1 (AZFI; YOR113W), Multicopy suppressor of SNF1 mutation (MSN4), GlyColysis Regulation 1 (GCR1), GCR2 and PseudoHyphal Determinant 1 (PHD1; YKE043W).
- Stel2 Sterile 12
- Hapl Heme Activator Protein 1
- AZFI Asparagine -rich Zinc-Finger 1
- MSN4 Multicopy suppressor of SNF1 mutation
- GCR1 GlyColysis Regulation 1
- PseudoHyphal Determinant 1 PseudoHyphal Determinant 1
- a preferred artificial yeast promoter region according to the invention comprises a first enhancer element at position -350 ⁇ 25 nucleotides selected from an Asparagine-rich Zinc-Finger 1 (AZFI; YOR113W) binding element and a Multicopy suppressor of SNF1 mutation (MSN4) binding element.
- AZFI Asparagine-rich Zinc-Finger 1
- MSN4 Multicopy suppressor of SNF1 mutation
- AZFI is a Cys2His2 zinc finger transcription factor that activates transcription of genes involved in carbon metabolism, energy production on glucose, cell wall organization and biogenesis on glycerol-lactate.
- AZFI binds a consensus sequence 5’-AAMRGMA, preferably 5’-AAAAGAA.
- MSN4 (YKL062W) is also a zinc finger protein that activates genes in response to several stresses, including heat shock, osmotic shock, oxidative stress, low pH, glucose starvation, sorbic acid and high ethanol concentrations. MSN4 binds to a consensus sequence 5’-CCCCT, preferably 5’-RVCCCCYR.
- a preferred artificial yeast promoter region according to the invention comprises a second enhancer element at position -600 ⁇ 50 nucleotides is selected from a GCR1 binding element, a GCR2 binding element, and a PHD1 binding element.
- GlyColysis Regulation 1 (GCR1; YPL075W) is a transcriptional activator that drives expression of glycolytic and ribosomal genes. GCR1 binds to a core 5'- GGAAG sequence, termed CT box, preferably 5’-WGGAWGMY).
- GCR2 (YNL199C) also is a transcriptional activator that drives expression of glycolytic and ribosomal genes. GCR2 interacts and functions with the DNA-binding protein GCR1. GCR2 binds to a core 5’-WGGAAGNM sequence.
- PseudoHyphal Determinant 1 (PHD1; YKL043W) is a transcriptional activator that enhances pseudohyphal growth. PHD1 binds to a core 5’- VMTGCRKV sequence.
- a preferred artificial yeast promoter region is able to drive expression of a downstream protein in several yeasts.
- Said yeasts preferably include at least one of Kluyverontyces marxianus, Kluyveromyces lactis, Komagataella pastoris, Komagataella phaffii, Ogataea angusta, Yarrowia lipolytica, Schizosaccharomyces pom.be, Rhodotorula mucilaginosa and Candida famata. and Saccharomyces cerevisiae, preferably at least in one of K. phaffii, Y. lipolytica and S. cerevisiae, more preferably at least two of K. phaffii, Y. lipolytica and S. cerevisiae.
- a preferred artificial yeast promoter region comprises a nucleotide sequence that is at least 60 % identical to one or more of SEQ ID NO:s 1-33, preferably at least 80 % identical to one or more of SEQ ID NO:s 1-33, over a length of at least 600 nucleotides.
- Said preferred artificial yeast promoter region comprises a nucleotide sequence that is at least 85 % identical, at least 90 % identical, at least 91 % identical, at least 92 % identical, at least 93 % identical, at least 94 % identical, at least 95 % identical, at least 96 % identical, at least 97 % identical, at least 98 % identical, at least 99 % identical, at least 100 % identical to one or more of SEQ ID NO:s 1-33 over a continuous stretch of at least 600 nucleotides, more preferred at least 650 nucleotides, more preferred at least 700 nucleotides, more preferred at least 750 nucleotides, more preferred over their full length to one or more of SEQ ID NO:s 1-33.
- the invention further provides a method of producing an artificial yeast promoter region, comprising a TATA box at position -90 ⁇ 15 nucleotides (nt) and/or a TATA box at position -160 ⁇ 15 nt, an enhancer element at position -350 ⁇ 25 nucleotides, and a second enhancer element at position -600 ⁇ 50 nucleotides, wherein all positions are relative to the start codon ATG, wherein the enhancer elements are not positioned at their natural distance to the start codon, and wherein the sequences in between the indicated TATA boxes and enhancer elements lack known repressor elements.
- Said first enhancer element at position -350 ⁇ 25 nucleotides preferably is selected from AZFI (5’-AAMRGMA) and MSN4 (5’-RVCCCCYR).
- Said second enhancer element at position -600 ⁇ 50 nucleotides preferably is selected from a GCR1 binding element, preferably 5’-WGGAWGMY, a GCR2 binding element, preferably 5’-WGGAAGNM, and a PHD1 binding element, preferably 5’-VMTGCRKV.
- sequences in between the indicated TATA boxes and enhancer elements may be selected from existing yeast promoter regions and preferably comprise shuffled sequences from existing yeast promoter regions.
- Known sequences that may bind to transcriptional repressor elements such as ACR1 (5’-ATGACGTCA; Vincent and Struhl, 1992. Mol Cell Biol 12: 5394-5405), Roxl (WTTGWW; Pevny and Lovell-Badge, 1997. Curr Opin Genet Dev 7: 338-344), and Rgt 1 (5'- CGGANNA; Kim, 2009. Biochimie 91: 300-303), preferably are avoided.
- an artificial yeast promoter region preferably is adjusted to mimic the GC-content of a yeast host organism.
- an artificial yeast promoter region may comprise a GC content of between 30-50 %.
- a GC content of 49 % for optimal expression in S. cerevisiae (GC content of 38.3 %), an artificial yeast promoter region may comprise a GC content of between 40-60 %.
- the invention further provides an expression construct comprising an artificial yeast promoter region of the invention, for expression of a protein of interest in a yeast.
- the expression construct preferably comprises a nucleotide sequence encoding a protein of interest under control of the artificial yeast promoter region.
- Said expression construct is either a construct that integrates into the yeast host genome, preferably at a pre-selected position in the yeast host genome, or an episomal expression vector.
- Expression constructs typically contain a yeast promoter and terminator sequences and a yeast selectable marker cassette, as is known to a person skilled in the art.
- Most yeast vectors can be propagated and amplified in E. coli to facilitate cloning.
- these constructs also contain an E. coli origin of replication and a selectable marker such as, for example, a betalactamase (Bia) gene for resistance to ampicillin.
- an yeast expression construct may include a secretion leader amino acid sequence that efficiently directs a protein of interest outside of the yeast host cell into the growth medium.
- Said protein of interest is preferably selected from a pharmacologically active protein, an antibody or antibody fragment, a therapeutic protein, a peptide such as peptide hormone or an antimicrobial peptide, an enzyme such as a cellulase, a protease, a protease inhibitor, an aminopeptidase, an amylase, a carbohydrase, a carboxypeptidase, a catalase, a chitinase, a cutinase, a deoxyribonuclease, an esterase, an alpha-galactosidase, a beta- galactosidase, a glucoamylase, an alphaglucosidase, a beta-glucosidase, an invertase, a laccase, a lipase, a mannanase, a mutanase, an oxidase, a pectinolytic
- a nucleotide sequence encoding a protein of interest is preferably codon optimized or codon harmonized for expression in a yeast.
- the term “codon optimized”, as is used herein, refers to the selection of codons in a nucleotide sequence encoding a protein of interest for optimal expression of the protein of interest in a yeast host cell.
- a single amino acid may be encoded by more than one codons. For example, arginine and leucine are each encoded by a total of 6 codons. Codon optimization, i.e. the selection of a preferred codon for a specific yeast cell at every amino acid residue, plays a critical role, especially when proteins are expressed in a heterologous system.
- codon optimization may play a role in achieving high gene expression levels, other factors such as secondary structure of the messenger RNA also need to be considered. Codon optimization is offered by commercial institutions, such as ThermoFisher Scientific, called Invitrogen GeneArt Gene Synthesis, GenScript, called GenSmartTM Codon Optimization, or GENEWIZ, called GENEWIZ’s codon optimization tool.
- Codon harmonized refers to the alignment of codon usage frequencies with those of the expression yeast, particularly within putative inter-domain segments where slower rates of translation may play a role in protein folding. Codon harmonization may be accomplished by algorithms such as provided by Angov et al., 2011 (Angov et al., 2011. In: Evans and Xu (eds) Heterologous Gene Expression in E. coli. Methods in Molecular Biology (Methods and Protocols), vol 705. Humana Press; Claassens et al., 2017. PLoS One 12: e0184355.
- gene products expressed from heterologous genes maybe more prone to degradation caused by proteolytic activity than proteins that are naturally expressed in a yeast cell. Such proteins do not naturally occur in the environment wherein they are secreted and may thus be more prone to degradation. Care has to be taken not to include proteolytic cleavage sites in the protein of interest for a proteolytic enzyme from the host yeast cell.
- one or more conserved amino acid alterations in which an aliphatic amino acid residue is replaced for another aliphatic amino acid residue, a hydroxyl or sulfur/selenium-containing amino acid residue is replaced for another hydroxyl or sulfur/selenium-containing amino acid residue, an aromatic amino acid residue is replaced for another aromatic amino acid residue, a basic amino acid residue is replaced for another basic amino acid residue, and an acidic amino acid residue or amide thereof is replaced for another acidic amino acid residue or amide thereof, may be engineered in the protein of interest to efficiently stop degradation.
- Said conserved amino acid replacements can be made for aliphatic amino acid residues glycine, alanine, valine, leucine, and isoleucine; hydroxyl or sulfur/selenium-containing amino acid residues serine, cysteine, selenocysteine, threonine and methionine, aromatic amino acid residues phenylalanine, tyrosine, and tryptophan, basic amino acid residues histidine, lysine, and arginine; and acidic amino acid residues and their amides aspartate, glutamate, asparagine, and glutamine.
- the invention further provides a yeast host cell, comprising an artificial yeast promoter region or an expression construct according to the invention.
- Said yeast host cell preferably is selected from Candida hispaniensis, Kluyveromyces marxianus, Kluyveromyces lactis, Komagataella phaffii, Ogataea angusta, Yarrowia lipolytica, and Saccharomyces cerevisiae, more preferably K phaffii, Y. lipolytica or S. cerevisiae.
- the invention further provides a method of producing a protein of interest in a yeast host cell, comprising providing an expression construct according to invention, wherein the expression of a protein of interest is controlled by an artificial yeast promoter region according to the invention, transforming a yeast cell with the expression construct; expressing the protein of interest; and, optionally, at least partly purifying the protein of interest.
- Said transformation preferably involves the integration of the expression construct in the genome of the yeast host cell.
- This integration may be performed randomly, or at a chosen locus of the genome of the yeast host cell by homologous recombination, for example through the use of Cre/Zox or a CRISPR-Cas recombination system.
- the robust and precise integration of an expression construct at a specific locus of the yeast genome allows stable, high expression levels of a protein of interest in a yeast host cell. Said high expression levels in general are reproducible for different proteins of interest.
- the invention further provides a method of producing a protein of interest in a yeast host cell, comprising an expression construct wherein the expression of a protein of interest is controlled by an artificial yeast promoter region according to the invention, expressing the protein of interest; and, optionally at least partly purifying the protein of interest.
- a yeast host cell expressing the protein of interest under control of an artificial yeast promoter region may be selected that has correctly integrated the expression that expresses the protein of interest.
- a selected yeast host cell may be grown, for example, in fed-batch or fermenter cultures, to very high cell densities reaching up to 150 g cell dry weight per litre.
- Purification of a protein of interest may comprise a series of processes intended to isolate one or more proteins from a complex mixture, usually cells, tissues, and/or growth medium.
- Various purification strategies can be followed.
- proteins can be separated based on size, for example in a method called size exclusion chromatography.
- proteins can be purified based on charge, e.g. through ion exchange chromatography or free-flow- electrophoresis, or based on hydrophobicity (hydrophobic interaction chromatography). It is also possible to separate proteins based on molecular conformation, for example by affinity chromatography.
- Said purification may involve the use of a specific tag, for example at the N-terminus and/or C-terminus of the protein.
- the proteins may be concentrated. This can for example be carried out with lyophilization or ultrafiltration.
- a protein of interest may be tagged in order to facilitate purification of the protein.
- a tag refers to the addition of a peptide to the amino (N) or carboxy (C) terminus of a protein. The addition of a tag allows to isolate or immobilize a protein.
- Commonly used tags include a poly-histidine tag such as a 6x(His) tag, a myc tag, a glutathione-S-transferase tag, a HiBiT tag (Promega, Madison, Wisconsin), a FLAG tag, a HA tag, or multimeric tags such as a triple FLAG tag If required, a protein of interest may be co-expressed in a yeast host cell together with one or more proteins that may increase correct folding of a recombinantly expressed protein of interest in a yeast host cell.
- one or more proteins such as a protein disulfide isomerase, for example protein disulfide isomerase PDI1 (YCL043C), ER protein Unnecessary for Growth (EUG1, YDR518W), or Multicopy suppressor of PDI1 deletion (MPD1; YOR288C); a flavin- linked sulfhydryl oxidase, for example Essential for Respiration and Viability (ERV2; YPR037C); and /or thiol oxidase such as ER Oxidation or Endoplasmic Reticulum Oxidoreductin (ERO1; YML130C), may be overexpression in a yeast host cell to assist in correct folding of a protein of interest.
- a protein disulfide isomerase for example protein disulfide isomerase PDI1 (YCL043C), ER protein Unnecessary for Growth (EUG1, YDR518W), or Multicopy suppressor
- Genes encoding one or more of the indicated Saccharomyces genes, or a related gene from another organism such as a fungus or another yeast, may be co-expressed in the yeast host cell as an auxiliary protein to assist in the folding of the protein of interest.
- auxiliary proteins or chaparones may include a spliced version of Homologous to Atf/Crebl (HAC1; YFL031W), an ATPase such as KARyogamy 2 (KAR2; YJL034W), a glutathione peroxidase such as a phospholipid hydroperoxide glutathione peroxidase, for example glutathione peroxidase (GPX1; YKL026C), and proteins that may enhance translocation of the protein of interest out of the yeast host cell into the culture medium such as SECretory 1 (SEC1; YDR164C) and Suppressor of Loss of Yptl 1 (SLY1; YDR189W).
- SECretory 1 SEC1; YDR164C
- Suppressor of Loss of Yptl 1 SLY1; YDR189W
- Tuning of expression is required when building synthetic pathways within organisms such as yeasts.
- tuning of individual protein expression levels is desired to optimize many industrial biotechnological processes.
- the promoter region may be changed to fine tune the transcription level and consequently the amount of protein produced. Fine tuning of individual expression levels of proteins that function in a cascade may enhance the overall yield of the final product.
- Such pathways include, for example, the production of a biofuel such as ethanol, 1-butanol and isopropanol, for which enzymes such as acetyl-CoA C- acyltransferase (EC 2.3.1.16; for example Peroxisomal Oxoacyl Thiolase 1 (POTI; YIL160C), acetoacetyl-CoA transferase, for example ERGosterol biosynthesis 10 (ERG 10; YPL028W), and an acetoacetate decarboxylase play an important role (Nandy and Srivastava, 2018.
- acetyl-CoA C- acyltransferase EC 2.3.1.16
- POTI Peroxisomal Oxoacyl Thiolase 1
- acetoacetyl-CoA transferase for example ERGosterol biosynthesis 10 (ERG 10; YPL028W)
- an acetoacetate decarboxylase play an important role
- Microbiol Res 207: 83-90 the breakdown of a carbohydrate such as cellulose, which includes the tuning of expression levels of several enzymes including, for example, endoglucanases and cellulase (Claes et al., 2020. Metabolic Engineering 59: 131-141), and production of a biopolyester such as polyhydroxyalkanoates (PHA), for which expression of, for example, B-ketothiolase, NADPH-linked acetoacetyl-CoA reductase and PHA synthase, needs to be carefully finetuned (Terentiev et al., 2004. Applied Microbiol Biotech 64: 376-381).
- PHA polyhydroxyalkanoates
- tocochromanol which term refers to amphipathic molecules with a hydrophobic isoprenoid- derived hydrocarbon tail and a polar aromatic head obtained from the shikimate pathway, and which include a, B, y, 5-tocopherols and tocotrienols.
- Tocotrienols are formed from two precursors, homogentisic acid (HGA) and geranylgeranyl pyrophosphate (GGPP).
- HGA is synthesized from 4-hydroxyphenylpyruvate (4-HPP) under catalysis of 4- hydroxyphenylpyruvate dioxygenase (HPPD), while GGPP is derived from 2C- Methyl-D-erythritol-4-phosphate (MEP) pathway.
- HPPD 4-hydroxyphenylpyruvate dioxygenase
- GGPP is derived from 2C- Methyl-D-erythritol-4-phosphate (MEP) pathway.
- alkaloids have a wide range of pharmacological activities including antimalarial (e.g. quinine), antiasthma (e.g. ephedrine), anticancer (e.g. homoharringtonine), cholinomimetic (e.g. galantamine), vasodilatory (e.g. vincamine), anti arrhythmic (e.g. quinidine), analgesic (e.g. morphine), antibacterial (e.g. chelerythrine), and antihyper glycemic activities (e.g. piperine).
- antimalarial e.g. quinine
- antiasthma e.g. ephedrine
- anticancer e.g. homoharringtonine
- cholinomimetic e.g. galantamine
- vasodilatory e.g. vincamine
- anti arrhythmic e.g. quinidine
- analgesic e.g. morphine
- Example 1 Engineering of synthetic promoters by rational shuffling method Engineered promoter sequences were shuffled in the following way. One or two core sequences with a TATA-Box element or TATA- Boxdike element at position -90 ⁇ 15 bp and/or -160 ⁇ 15 bp were linked together without changing the relation of the core promoter to the start codon ATG. TATA-Box-like element were changed to TATA-Box sequences.
- a first enhancer region was linked to the core element in a way that the binding sites of Saccharomyces cerevisiae transcription factor AZFI (5’-AAMRGMA) or MSN 4 (5’-RVCCCCYR) start a position -350 bp.
- a second enhancer element exhibit GCRl-bs (5’-WGGAWGMY), GCR2-bs (5’- WGGAAGNM), or PHDl-bs (5’-VMTGCRKV) at position -600 bp, wherein -bs denotes binding sequence. Thereby the elements were not set at their natural distance to the start codon. Additional point mutations were set to partly prevent specific enzyme cleavage sites within the promoter sequences.
- the different promoter sequences were ordered as synthetic strings or gene product from Twist Bioscience (San Francisco, CA, USA) or Invitrogen GeneArt Gene Synthesis (Thermo Fisher Scientific Inc.) with appropriate sequence overhang for the dedicated vector system.
- the engineered promoter sequences and the reference promoter of Gen GAP1 were cloned via Xmal and EcoRI restriction sites into an expression vector (pKN95). This contains the yellow fluorescent protein YFP (Venus) gene in addition to a kanMX gene as a selection marker.
- Expression vectors and empty vector (pKNl; Nord et al., 1997. Nature Biotech 15: 772-777) were transformed into competent K. phaffii cells by electroporation. To characterize the YFP expression under control of different promoters, all strains were cultivated as biological triplicates in deepwell plates.
- the cultivation was performed at 28 °C and 70 % humidity in a volume of 1.5 ml YPD medium (1 % w/v yeast extract, 2 % w/v peptone and 2 % w/v glucose), supplemented with geneticin (G418; 500 pg/ml).
- the medium was inoculated with three colonies of each respective strain. After 90 h, the samples were diluted 1:20 with fresh medium. 200 pl of each sample was pipetted into optical bottom plates (Thermo Scientific 96 well, black) in technical triplicates. Fluorescence (excitation 485 nm I emission 520 nm) and GD600 were measured in plate reader (FLUOstar Omega, BMG Labtech).
- the carbon source was additional exchanged to provide glycerol and/or methanol instead of glucose.
- the measured fluorescence was normalized to OD600 and the reference promoter GAP1 was set to 1.
- the promoters EPK1 to 5 were designed at a later stage based on the good promoters. See Figure 1.
- the promoters EPK18 to 23 showed a lower fluorescence intensity relative to reference promoter GAP1, so these are interesting for other applications like the expression of auxiliary enzymes.
- individual genes can be up or down regulated.
- Figure 3 shows the GFP fluorescence normalized to the GD600 after 24 h.
- the reference promoter TEF1 was set at 1.
- the strain with the construct EPK6 had a comparable fluorescence intensity than the TEF1 control.
- the strains bearing the promoters EPK7, EPK8, EPK9 EPK10, EPK11 and EPK12 showed a significant stronger fluorescence than strains with reference promoter ( Figure 3A).
- the strains bearing the promoters EPK27, EPK28, EPK29 EPK30, EPK31, EPK32 and EPK33 showed a similar fluorescence to strains with effective reference promoter (Figure 3B).
- the different promoter fragments and the reference promoter PGK1 were cloned in front of the YFP gene into a 2g expression vector containing an uracil cassette as a selective marker (Lee et al. 2015. ACS Synth. Biol. 2015, 4, 9, 975-986).
- These YFP expression vectors were chemically transformed into competent S. cerevisiae (CEN.PK2 1C) cells with the Li-Acetate, single stranded carrier DNA transformation protocol according to Gietz and Schiestl, 2007 (Gietz and Schiestl, 2007. Nat Protoc 2: 31-34).
- CEN.PK2 1C competent S. cerevisiae
- Example 5 Application of synthetic promoters for metabolic engineering of S. cerevisiae: tocochromanol production a. Concent for regulation of gene expression for tocochromanol production in yeast
- the group of tocochromanols comprises tocotrienols and tocopherols, commonly known as Vitamin E, and are naturally produced by photo autotrophic organisms. Due to rising demands in food, feed and cosmetic industry a sustainable production process for tocochromanols is required. The goal of these experiments is to obtain microorganisms as biotechnological production hosts.
- Tocochromanols consist of a chromanol group, which is derived from homogentisic acid, and an isoprene chain that is derived from geranylgeranyl-diphosphate (GGPP). These two precursors can be converted into all Vitamin E isoforms by heterologous genes from plants and cyanobacteria.
- ARO3 UniProt #P14843
- ARO4 P32449
- these enzymes should be expressed in a feedback resistant version (Aro3K222L, in which a lysine (K) at position 222 is altered into a Leucine(L); and Aro4K229L, in which a lysine (K) at position 229 is altered into a Leucine (L)).
- ARO1 which encodes a pentafunctional enzyme
- ARO7 which encodes a pentafunctional enzyme
- ARO7 P32178
- TRP2 P00899
- PHA2 P32452
- genes of degrading pathways need to be deleted or downregulated (ARO8 (P53090), ARO9 (P38840), ARO10 (Q06408) and PDC5 (P16467)).
- HPP hydroxyphenylpyruvate
- the second precursor of the isoprene chain is geranylgeranyl- diphosphate (GGPP).
- GGPP geranylgeranyl- diphosphate
- HMG1 P12683
- BTS1 Q 12051
- Q1L6K3 a stronger heterologous variant like crtE from Xanthophyllomyces dendrorhous
- the two precursors homogentisic acid and GGPP will be prenylated by a heterologous homogentisat phytyl-transferase (HPT) and further cyclized be the tocopherol cyclase (TC) for tocotrienol production.
- HPT heterologous homogentisat phytyl-transferase
- TC tocopherol cyclase
- GGPP needs to be reduced by a heterologous GGPP reductase into phytyl-diphosphat (PDP).
- y-TM7 y tocopherol methyltransferase
- MPBQMT 2-methyl-6-phytylbenzoquinol methyltransferase
- the synthetic promoter EPK14 was used in a project of metabolic engineering of S. cerevisiae for enhanced geranylgeraniol (GGOH) production.
- Two different production strains JBY6 and JBY12 were generated from the modified CEN.PK2- 1C strain (Entian and Kbtter, 2007. Methods Microbiol 36: 629-666).
- the enzyme geranyl- geranyl diphosphate synthase (GGPPS) which is encoded by BTS1 was shown to be crucial for GGOH production from GGPP.
- the two strains JBY6 (leu2A::pPGKl-BTSl-tADHl) and JBY12 (hoA::EPK14-BTSl-tADHl) were created by integration of a BTS1 overexpression cassette with either the reference promoter PGK1 (JBY6) or the synthetic promoter EPK14 (JBY12).
- the strains were verified on selective agar plates and by PCR methods. Since BTS1 is still limiting the GGOH production, the GGPPS was additionally overexpressed on 2q plasmids. All strains were cultivated for 144 h in 50 ml selective synthetic minimal medium + 2 % glucose in biological duplicates in shake flasks (30 °C, 180 rpm).
- the strains JBY6, harbouring the PGK1 promoter and JBY12, bearing the synthetic promoter EPK14 were able to produce similar amounts of GGOH ( ⁇ 5 mg/L). Moreover, if BTS1 is additionally expressed on 2p plasmids the strain JBY12 is producing 18.55 mg/L whilst JBY6 did only produce 12.52 mg/L. This shows, exemplary for EPK14, that the synthetic promoters are applicable for gene expression in S. cerevisiae.
- one of the weak promoters can be used to downregulate the competing ergosterol pathway. Either, farnesyl-diphosphate can be converted into the desired geranylgeranyl-diphosphate or into a precursor of ergosterol by ERG9 (P29704).
- ERG9 P29704
- the strong promoter EPK14 already leads to higher expression of BTS1, but the effect of upregulation can be enhanced by using one of the weak promoters so weaken the ERG9 expression and channel the flux from farnesyl-diphosphate into geranylgeranyl-diphosphate production.
- the following example shows the applicability of the synthetic promoter EPK15 for heterologous gene expression in S. cerevisiae.
- a yeast strain was constructed which is producing the two intermediates: homogentisic acid and GGPP.
- two heterologous enzymes, the prenylase HPT (P73726)and the cyclase VTE1 (829413) are needed to form 5-tocotrienol. Both heterologous enzymes were integrated into the leu2 locus.
- the synthetic promoter EPK15 was used in front of the heterologous HPT gene of Synechocystis spec, and a truncated version of the VTE1 (deletion of the first 47 amino acids) gene was expressed under the control of PGK1 (JBY20).
- This strain was cultivated in biological triplicates in 50 ml YPD medium + 15 ml dodecane overlay at 30 °C and 180 rpm. After 144 h, 1 ml of the dodecane phase was harvested and measured in the HPLC Bio-LC (Dionex) using the Agilent Zorbax SB-C8 column (4.6 x 150 mm, 3.5 pm).
- Buffer A (ddH2O + 0.1 % formic acid) and buffer B (acetonitrile + 0.1 % formic acid) were run in a gradient up to 100 % buffer B for 40 min and delta tocotrienol was measured using UV detection at 300 nm. Furthermore, 5- tocotrienol was identified by mass determination in the LC-MS ([M+H]+ 397.3101). Using this strain, delta-tocotrienol was produced by S. cerevisiae, which gives another example for the usage of synthetic promoters for metabolic engineering in yeast.
- Example 6 Synthetic promoters for expression of App A from Escherichia coli in K. phaffii
- the promoters EPK2 and EPK3, and the reference promoter GAP1 were cloned into an expression vector via the restriction sites Xmal and EcoRI.
- This vector contains the AppA (P07102, amino acids 23-432) gene from E. coli in addition to a kanMX gene as a selection marker.
- AppA expression vectors as well as the empty vector were transformed into electro-competent K. phaffii cells. After expression of the enzyme, it is secreted into the culture supernatant so that phytase activity can be measured in the medium. The activity of phytase can therefore be used as a direct signal of promoter strength.
- the supernatant was diluted 1:80 with a sodium acetate buffer (250 mM HAc-NaAc buffer, pH 4.5 containing 0.01 % Tween20). Of this, 800 pl of phytate solution (7.5 mmol/1) was added to 400 pl. After incubation for 30 min at 37 °C, the reaction was stopped and mixed thoroughly. This was followed by incubation at room temperature (1 min) and then centrifugation of the reaction mixture at llOOOxg. The enzyme activity was measured in triplicates in 96-well plates. The absorbance were measured at 415 nm in a plate reader (FLUOstar Omega, BMG Labtech).
- the measured activity was normalized to OD600 and the reference promoter GAP1 was set to 1 ( Figure 7).
- the carbon source was exchanged to provide glycerol or methanol instead of glucose.
- promoters are very strong. Some of the promoters showed weaker fluorescence intensities compared to the reference promoter GAP1. These promoters are interesting for metabolic engineering, as being able to regulate multiple genes individually.
- auxiliary enzymes such as PDI (B3VSN1). It is known that the enzyme PDI can increase the correct folding rate of recombinantly expressed proteins, especially in the presence of additional disulfide bridges.
- auxiliary enzymes like ERV2 (C4R490), EUG1 (P32474), ERO1 (A0A1B2J869) and MPDI (C4QVB2).
- the invertase SUC2 (P00724) is an enzyme with which sucrose would be available as a carbon sources.
- AAAAC AT C AAGAAC AAAC AAGC T C AACT T GTCTTTTC T AAG AAC AAAGAAT AAAC AC AA AAAC AAAAAGT T T T T T T AAT T T T AAT C AAAAA
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP21210056.4 | 2021-11-23 | ||
EP21210056 | 2021-11-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023094429A1 true WO2023094429A1 (fr) | 2023-06-01 |
Family
ID=78770541
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2022/082939 WO2023094429A1 (fr) | 2021-11-23 | 2022-11-23 | Régions promotrices artificielles de levure |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2023094429A1 (fr) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20180371468A1 (en) * | 2016-02-22 | 2018-12-27 | Teknologian Tutkimuskeskus Vtt Oy | Expression system for eukaryotic organisms |
EP3690052A1 (fr) * | 2019-01-29 | 2020-08-05 | Clariant Produkte (Deutschland) GmbH | Promoteur chimérique pour une utilisation dans l'ingénierie métabolique |
-
2022
- 2022-11-23 WO PCT/EP2022/082939 patent/WO2023094429A1/fr active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20180371468A1 (en) * | 2016-02-22 | 2018-12-27 | Teknologian Tutkimuskeskus Vtt Oy | Expression system for eukaryotic organisms |
EP3690052A1 (fr) * | 2019-01-29 | 2020-08-05 | Clariant Produkte (Deutschland) GmbH | Promoteur chimérique pour une utilisation dans l'ingénierie métabolique |
Non-Patent Citations (37)
Title |
---|
"Methods in Enzymology: Guide to Molecular Cloning Techniques", vol. 152, 1987, ACADEMIC PRESS INC. |
ANGOV ET AL.: "Heterologous Gene Expression in E. coli. Methods in Molecular Biology (Methods and Protocols", vol. 705, 2011, HUMANA PRESS |
BASEHOAR ANDREW D ET AL: "Identification and Distinct Regulation of Yeast TATA Box-Containing Genes Graduate Program in Statistics", CELL, 5 March 2004 (2004-03-05), pages 699 - 709, XP055920041, Retrieved from the Internet <URL:https://reader.elsevier.com/reader/sd/pii/S0092867404002053?token=9F8E294249C59D8C8B792AAD2941458561E1718D1C407C9A900AD4A130716646CF3D902A0DF3E380F423839B74F9FFD8&originRegion=eu-west-1&originCreation=20220516121945> [retrieved on 20220511] * |
BRUDER ET AL., MICROB CELL FACT, vol. 15, 2016, pages 127 |
CLAASSENS ET AL., PLOS ONE, vol. 12, 2017, pages e0184355 |
CLAES ET AL., METABOLIC ENGINEERING, vol. 59, 2020, pages 131 - 141 |
DATABASE GenBank [online] 18 November 2008 (2008-11-18), YANG F.X. ET AL: "Saccharomyces cerevisiae 3-phosphoglycerate kinase (PGK1) gene, promoter region", XP055921437, Database accession no. FJ415226 * |
DATABASE GenBank [online] 4 March 2018 (2018-03-04), PAIVA D.P. ET AL: "Saccharomyces cerevisiae strain JP1 translation elongation factor 1 (TEF1) gene, promoter region", XP055921442, Database accession no. KY704477.1 * |
DAVIS ET AL.: "Basic Methods in Molecular Biology", 1995, ELSEVIER SCIENCE PUBLISHING, INC. |
DEBAILLEUL ET AL., MICROB CELL FACT, vol. 12, 2013, pages 129 |
DECOENE THOMAS ET AL: "Modulating transcription through development of semi-synthetic yeast core promoters", PLOS ONE, vol. 14, no. 11, 5 November 2019 (2019-11-05), pages e0224476, XP055918908, DOI: 10.1371/journal.pone.0224476 * |
DONCZEW RAFAL ET AL: "Mechanistic Differences in Transcription Initiation at TATA-Less and TATA-Containing Promoters", vol. 38, no. 1, 1 January 2018 (2018-01-01), US, XP055921738, ISSN: 0270-7306, Retrieved from the Internet <URL:https://journals.asm.org/doi/pdf/10.1128/MCB.00448-17> DOI: 10.1128/MCB.00448-17 * |
ENTIANKOTTER, METHODS MICROBIOL, vol. 36, 2007, pages 629 - 666 |
FENG XIAOFAN ET AL: "Saccharomyces cerevisiae Promoter Engineering before and during the Synthetic Biology Era", BIOLOGY, vol. 10, no. 6, 6 June 2021 (2021-06-06), pages 504, XP055918958, DOI: 10.3390/biology10060504 * |
GIETZSCHIESTL, NAT PROTOC, vol. 2, 2007, pages 31 - 34 |
GORDAN ET AL., GENOME BIOL, vol. 12, 2011, pages R125 |
HITTINGER, TRENDS GENET, vol. 29, 2013, pages 309 - 317 |
IWAMI RYO ET AL: "The function of Spt3, a subunit of the SAGA complex, in <i>PGK1</i> transcription is restored only partially when reintroduced by plasmid into <i>taf1 spt3</i> double mutant yeast strains", GENES AND GENETIC SYSTEMS, vol. 95, no. 3, 1 June 2020 (2020-06-01), JP, pages 151 - 163, XP055918912, ISSN: 1341-7568, DOI: 10.1266/ggs.20-00004 * |
JOHN BLAZECK ET AL: "Controlling promoter strength and regulation in Saccharomyces cerevisiae using synthetic hybrid promoters", BIOTECHNOLOGY AND BIOENGINEERING, JOHN WILEY, HOBOKEN, USA, vol. 109, no. 11, 17 May 2012 (2012-05-17), pages 2884 - 2895, XP071146070, ISSN: 0006-3592, DOI: 10.1002/BIT.24552 * |
KIM ET AL., NAT BIOTECHNOL, vol. 28, 2010, pages 617 - 623 |
KIM, BIOCHIMIE, vol. 91, 2009, pages 300 - 303 |
LEE ET AL., ACS SYNTH. BIOL., vol. 4, no. 9, 2015, pages 975 - 986 |
NANDYSRIVASTAVA, MICROBIOL RES, vol. 207, 2018, pages 83 - 90 |
NASEEB ET AL., INT J SYST EVOL MICROBIOL, vol. 67, 2017, pages 2046 - 2052 |
NORD ET AL., NATURE BIOTECH, vol. 15, 1997, pages 772 - 777 |
PARRET ET AL., CURRENT OPINION STRUCT BIOL, vol. 38, 2016, pages 155 - 162 |
PEVNYLOVELL-BADGE, CURR OPIN GENET DEV, vol. 7, 1997, pages 338 - 344 |
PYNE ET AL., NAT COMMUN, vol. 11, 2020, pages 3337 |
SAMBROOK ET AL.: "Molecular Cloning: A Laboratory Manual", 2014, COLD SPRING HARBOR LABORATORY PRESS |
SCHERENSGOFFEAU, GENOME BIOL, vol. 5, 2004, pages 229 |
SRINIVASANSMOLKE, NATURE, vol. 585, 2020, pages 614 - 619 |
STANBROUGH M ET AL: "Two transcription factors, Gln3p and Nil1p, use the same GATAAG sites to activate the expression of GAP1 of Saccharomyces cerevisiae", JOURNAL OF BACTERIOLOGY (PRINT), vol. 178, no. 8, 1 April 1996 (1996-04-01), US, pages 2465 - 2468, XP055921352, ISSN: 0021-9193, DOI: 10.1128/jb.178.8.2465-2468.1996 * |
STRUHL, CURRENT OPINION CELL BIOL, vol. 5, 1993, pages 513 - 520 |
TANG HONGTING ET AL: "Promoter Architecture and Promoter Engineering in Saccharomyces cerevisiae", METABOLITES, vol. 10, no. 8, 6 August 2020 (2020-08-06), pages 320, XP055918931, DOI: 10.3390/metabo10080320 * |
TERENTIEV ET AL., APPLIED MICROBIOL BIOTECH, vol. 64, 2004, pages 376 - 381 |
VINCENTSTRUHL, MOL CELL BIOL, vol. 12, 1992, pages 5394 - 5405 |
WELCH ET AL., PLOS ONE, vol. 4, 2009, pages e7002 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11555211B2 (en) | Recombinant production systems for prenylated polyketides of the cannabinoid family | |
Vogl et al. | Regulation of Pichia pastoris promoters and its consequences for protein production | |
ES2358086T3 (es) | Promotores aox1 mutantes. | |
Cogliati et al. | Regulation of mitochondrial electron transport chain assembly | |
US11555212B2 (en) | Process for the production of sulfated phenolic compounds using modified Escerichia coli | |
NZ580043A (en) | Improvement of protein production through increased expression of mutated start domain protein cert | |
CA2684650A1 (fr) | Systeme d'expression | |
WO2009091582A1 (fr) | PRODUCTION D'ACIDE R-α-LIPOÏQUE PAR UN PROCÉDÉ DE FERMENTATION UTILISANT DES MICRO-ORGANISMES GÉNÉTIQUEMENT MODIFIÉS | |
AU2012300885A1 (en) | Protein expression | |
US20210403959A1 (en) | Use of type i and type ii polyketide synthases for the production of cannabinoids and cannabinoid analogs | |
KR102345759B1 (ko) | 뉴클레아제 시스템의 녹-아웃에 의한 시험관 내 생합성 활성을 조절하기 위한 방법 | |
US20220325306A1 (en) | Biological processes for the production of aryl sulfates | |
EP3666287A1 (fr) | Construction et séquence pour amplification de l'expression génique | |
WO2018211028A1 (fr) | Production microbienne de nicotinamide riboside | |
US20220348974A1 (en) | Biotin synthases for efficient production of biotin | |
WO2020077367A1 (fr) | Biosynthèse d'homoériodictyol | |
WO2012044171A1 (fr) | Régulation de la traduction de gènes exprimés | |
US20220282227A1 (en) | Recombinant heme thiolate oxygenases | |
CA3196893A1 (fr) | Variants de l'acide cannabidiolique synthase ayant une activite amelioree pour une utilisation dans la production de phytocannabinoides | |
CN110938649A (zh) | 一种提高外源蛋白表达量的蛋白合成体系及其应用方法 | |
WO2023094429A1 (fr) | Régions promotrices artificielles de levure | |
AU2020274089A1 (en) | Expression of modified proteins in a peroxisome | |
WO2017163946A1 (fr) | Promoteur de type à induction | |
AU2022363796A1 (en) | Optimized biosynthesis pathway for cannabinoid biosynthesis | |
US20230193338A1 (en) | Genetic factor to increase expression of recombinant proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22821503 Country of ref document: EP Kind code of ref document: A1 |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112024010148 Country of ref document: BR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2022821503 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2022821503 Country of ref document: EP Effective date: 20240624 |